Palisade Bio Issues Warrants Exempt from Registration
Company Announcements

Palisade Bio Issues Warrants Exempt from Registration

Palisade Bio (PALI) has released an update to notify the public and investors about the unregistered sales of equity securities.

The current report details the incorporation of previously reported information regarding the issuance of Replacement Warrants and a Placement Agent Warrant. This issuance was conducted under an exemption from registration requirements as per Section 4(a)(2) of the Securities Act of 1933.

For further insights into PALI stock, check out TipRanks’ Stock Analysis page.

For a comprehensive understanding of the announcement, you can read the full document here.

Related Articles
TheFlyPalisade Bio price target lowered to $8 from $22.50 at Maxim
TheFlyPalisade Bio reports Q3 EPS ($2.32) vs. ($7.38) last year
TheFlyPalisade Bio expects cash to fund operations through 1Q25
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App